AddLife AB (publ) (FRA:1AD1)

Germany flag Germany · Delayed Price · Currency is EUR
13.28
+0.44 (3.43%)
Last updated: Feb 20, 2026, 8:02 AM CET
Market Cap1.64B +3.1%
Revenue (ttm)964.87M +1.5%
Net Income51.75M +122.2%
EPS0.42 +122.8%
Shares Outn/a
PE Ratio31.71
Forward PE23.05
Dividend0.07 (0.53%)
Ex-Dividend DateMay 9, 2025
Volumen/a
Average Volume159
Open13.28
Previous Close12.84
Day's Range13.28 - 13.28
52-Week Range12.40 - 19.01
Betan/a
RSI45.18
Earnings DateFeb 4, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1906
Employees 2,295
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 1AD1
Full Company Profile

Financial Performance

In 2025, AddLife AB's revenue was 10.44 billion, an increase of 1.52% compared to the previous year's 10.29 billion. Earnings were 560.00 million, an increase of 122.22%.

Financial numbers in SEK Financial Statements